PMID- 32359533 OWN - NLM STAT- MEDLINE DCOM- 20200713 LR - 20221207 IS - 1538-2990 (Electronic) IS - 0002-9629 (Print) IS - 0002-9629 (Linking) VI - 359 IP - 5 DP - 2020 May TI - Five-Year Glycemic Trajectories Among Healthy African-American and European-American Offspring of Parents With Type 2 Diabetes. PG - 266-270 LID - S0002-9629(20)30078-1 [pii] LID - 10.1016/j.amjms.2020.03.005 [doi] AB - BACKGROUND: Cross-sectional surveys report a higher prevalence of diagnosed type 2 diabetes mellitus (T2DM) in African Americans (AA) than European Americans (EA). We studied 5-year glycemic excursions among AA and EA in the Pathobiology of Prediabetes in A Biracial Cohort study, to assess ethnic disparities. MATERIALS AND METHODS: Pathobiology of Prediabetes in A Biracial Cohort followed normoglycemic offspring of parents with T2DM for 5 years, with serial assessments of oral glucose tolerance test , anthropometry, body fat, insulin sensitivity and beta-cell function. The primary outcome was progression to prediabetes (impaired fasting glucose and/or impaired glucose tolerance). We further analyzed 5-year changes in fasting (FPG) and 2-hour plasma glucose (2hrPG). RESULTS: One hundred and one (52 AA, 49 EA) out of 343 subjects developed prediabetes during follow-up. The change in FPG ranged from -24 mg/dl to +38 mg/dl. The FPG remained stable (+/- 5 mg/dl from baseline) in 50% of EA and 46.8% of AA and the 2hrPG remained stable (+/- 25 mg/dl from baseline) in 73.7% of EA and 71.0 % of AA during follow-up. The proportions with change in FPG of 5mg/dl to >25 mg/dl and 2hrPG of 25 mg/dl to >50 mg/dl were similar in EA and AA offspring, as were the 10th - 90th percentiles of the distribution of 5-year changes in FPG and 2hrPG. CONCLUSIONS: During 5 years of follow-up, black and white offspring of parents with T2DM exhibited remarkable phenotypic concordance of glycemic trajectories. Thus, parental history of T2DM may be a stronger factor than race/ethnicity in the prediction of longitudinal glycemic trends. CI - Copyright (c) 2020 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved. FAU - Razavi, Laleh N AU - Razavi LN AD - Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Tennessee Health Science Center, Memphis, Tennessee; Division of Endocrinology, Case Western Reserve University, Cleveland, Ohio. FAU - Ebenibo, Sotonte AU - Ebenibo S AD - Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Tennessee Health Science Center, Memphis, Tennessee. FAU - Edeoga, Chimaroke AU - Edeoga C AD - Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Tennessee Health Science Center, Memphis, Tennessee. FAU - Wan, Jim AU - Wan J AD - Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, Tennessee. FAU - Dagogo-Jack, Samuel AU - Dagogo-Jack S AD - Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Tennessee Health Science Center, Memphis, Tennessee; General Clinical Research Center, University of Tennessee Health Science Center, Memphis, Tennessee. Electronic address: sdj@uthsc.edu. LA - eng GR - R01 DK067269/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Observational Study PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20200309 PL - United States TA - Am J Med Sci JT - The American journal of the medical sciences JID - 0370506 RN - 0 (Blood Glucose) RN - 0 (Glycated Hemoglobin A) RN - 0 (Insulin) RN - 0 (hemoglobin A1c protein, human) SB - IM MH - Adult MH - Black or African American MH - Anthropometry MH - Blood Glucose/analysis MH - Body Mass Index MH - Diabetes Mellitus, Type 2/blood/*ethnology MH - Family Health MH - Female MH - Follow-Up Studies MH - Glucose Intolerance/diagnosis MH - Glucose Tolerance Test MH - Glycated Hemoglobin/analysis MH - Healthcare Disparities MH - Humans MH - Hyperglycemia/blood MH - Insulin/blood MH - Insulin Resistance MH - Insulin-Secreting Cells/cytology MH - Male MH - Middle Aged MH - Parents MH - Phenotype MH - Prediabetic State/blood/*ethnology MH - Prevalence MH - Treatment Outcome MH - United States/epidemiology MH - White People PMC - PMC7246091 MID - NIHMS1581377 OTO - NOTNLM OT - Dysglycemia OT - Impaired fasting glucose OT - Impaired glucose tolerance OT - Prediabetes OT - Race/Ethnicity COIS- Conflict of Interest: The authors have no conflict of interest to disclose regarding the content of this manuscript. EDAT- 2020/05/04 06:00 MHDA- 2020/07/14 06:00 PMCR- 2021/05/01 CRDT- 2020/05/04 06:00 PHST- 2019/11/13 00:00 [received] PHST- 2020/03/02 00:00 [revised] PHST- 2020/03/04 00:00 [accepted] PHST- 2020/05/04 06:00 [entrez] PHST- 2020/05/04 06:00 [pubmed] PHST- 2020/07/14 06:00 [medline] PHST- 2021/05/01 00:00 [pmc-release] AID - S0002-9629(20)30078-1 [pii] AID - 10.1016/j.amjms.2020.03.005 [doi] PST - ppublish SO - Am J Med Sci. 2020 May;359(5):266-270. doi: 10.1016/j.amjms.2020.03.005. Epub 2020 Mar 9.